High-sensitivity cardiac troponin (hs-cTn) assays facilitate the ruling-out of myocardial infarction (MI) but identify a high number of patients with elevated troponin levels but without MI. Consequently, the term myocardial injury was included in the latest universal definition of MI. In the High-STEACS trial, use of a hs-cTnI assay was safe but had no prognostic benefit.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Impact of impaired renal function on kinetics of high-sensitive cardiac troponin following cardiac surgery
Clinical Research in Cardiology Open Access 29 January 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Mehta, S. R. et al. Early versus delayed invasive intervention in acute coronary syndromes. N. Engl. J. Med. 360, 2165–2175 (2009).
Thygesen, K. et al. Fourth universal definition of myocardial infarction (2018). Eur. Heart J. https://doi.org/10.1093/eurheartj/ehy462 (2018).
Keller, T. et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N. Engl. J. Med. 361, 868–877 (2009).
Hamm, C. W. et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 32, 2999–3054 (2011).
Mills, N. L. et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 305, 1210–1216 (2011).
Shah, A. S. V. et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet 392, 919–928 (2018).
Keller, T. et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 306, 2684–2693 (2011).
Neumann, J. T. et al. Diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm. JAMA Cardiol. 1, 397–404 (2016).
Roffi, M. et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 37, 267–315 (2016).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03005158 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Keller, T., Hamm, C.W. High-sensitivity cardiac troponin assays: finally ready for prime time?. Nat Rev Cardiol 16, 135–136 (2019). https://doi.org/10.1038/s41569-018-0122-9
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41569-018-0122-9
This article is cited by
-
Impact of impaired renal function on kinetics of high-sensitive cardiac troponin following cardiac surgery
Clinical Research in Cardiology (2025)
-
A one-pot purification-free strategy for biotinylated antibody preparation enables sensitive ELISA detection of cardiac troponin I-C complex
Analytical and Bioanalytical Chemistry (2025)
